Kotak Alternate Asset Managers Limited (KAAML) has bought Affirma Capital’s stake in nutraceuticals contract manufacturer Tirupati Medicare for Rs 1,050 crore ($122.6 million), giving the Singapore-based private equity firm a full exit, according to an announcement on Wednesday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
